Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-22

FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for ibuprofen by Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

SUPPL AP for IBUPROFEN (IBUPROFEN)